comparemela.com
Home
Live Updates
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for : comparemela.com
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for
-- Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery...
Related Keywords
New York
,
United States
,
London
,
City Of
,
United Kingdom
,
Mediarajin Kang
,
Prnewswire Benevolent
,
Anne Phelan
,
Eli Lilly
,
Maria Belvisi
,
Partnership Alliance
,
Astrazeneca
,
Head Of Research
,
Early Development
,
Benevolent Platform
,
Chief Scientific Officer
,
Idiopathic Pulmonary Fibrosis
,
Scrip Awards
,
Best Partnership Alliance
,
Rajin Kang
,
comparemela.com © 2020. All Rights Reserved.